Menu
Česky English
Path 23
532 23 1111

Conservative treatment versus surgery in spondylotic cervical myelopathy: a prospective randomised study

A prospective randomised 2-year study was performed to compare the conservative and operative treatment of mild and moderate forms of spondylotic cervical myelopathy (SCM). Forty-eight patients presenting with the clinical syndrome of SCM, with – a modified Japanese Orthopaedic Association (mJOA) score - of 12 points or more, - were randomised into two groups.

 Z, Kadaňka, J. Bednařík, S. Voháňka, O. Vlach, L. Stejskal, R. Chaloupka, D. Filipovičová, D. Šurelová, B. Adamová, O. Novotný, M. Němec, J. Jankových, I. Urbánek


Departments of Neurology+ and Orthopaedic Surgery* , Faculty Hospital Brno

Jihlavská 20, 639 00 Brno, Czech Republic.
Tel.: ++42-(0)5-43192501
Fax: ++42-(0)5-43192249
E-mail:

Department of Neurosurgery**, Central Military Hospital Prague

U Vojenské nemocnice 1200, 169 02 Prague, Czech Republic

Correspondence to: Zdeněk Kadaňka MD, Department of Neurology, Faculty Hospital Brno,

Address reprint requests to:

Zdeněk Kadaňka MD, Department of Neurology, Faculty Hospital Brno, Jihlavská 20, 639 00 Brno, Czech Republic.

Tel.: ++4205-43192501

Fax: ++4205-43192249

E-mail:

This study was supported by the Internal Grant Agency of the Ministry of Health of the Czech Republic N: 4732-3.

Running head: Treatment in spondylotic cervical myelopathy

 

Abstract

A prospective randomised 2-year study was performed to compare the conservative and operative treatment of mild and moderate forms of spondylotic cervical myelopathy (SCM). Forty-eight patients presenting with the clinical syndrome of SCM, with – a modified Japanese Orthopaedic Association (mJOA) score - of 12 points or more, - were randomised into two groups: group A, treated conservatively, consisted of 27 patients, mean age 55.6 ± 8.6 years, while group B was treated surgically (21 patients, mean age 52.7 ± 8.1 years). The clinical outcome was measured by the mJOA score, recovery rate (RR), quantified gait time, score of daily activities recorded by video, and evaluated by two observers blinded to the therapy and by the subjective assessment of the patients at 6, 12, and 24 months of the follow-up.

There was, on average, no significant change in mJOA score, recovery rate, or quantified gait time within either group during the 2- years of follow-up. In the surgery group there was a slight decline in the scores for daily activities and subjective evaluation. A comparison of the two groups showed no significant differences in changes over time in mJOA score, or quantified gait, but there were significant differences in the score of daily activities recorded by video at 24 months, which was a little lower in the surgical group, and also in RR and subjective evaluation, which were both worse in the surgical group at months 12 and 24. However; at month 6, this last parameter was significantly better in the surgical than in conservative group. Surgical treatment of mild and moderate forms of SCM in the present study design, comprising patients with no or very slow, insidious progression and a relatively long duration of symptoms, did not show better results than conservative treatment over the 2-year follow-up.

 

Key words: Spondylotic cervical myelopathy; conservative treatment; surgery

 

Introduction

Spondylotic cervical myelopathy (SCM) is the most frequent cause of the myelopathy in those over 50 [48]. It is believed to have a generally progressive course over a period of years, with sudden acceleration especially following a slight head and neck injury and leading to significant disability [24, 45, 49]. The treatment of SCM remains a problem, particularly in the mild and moderate forms without rapid progression. There is no strong evidence to show that decompressive surgery with an anterior or posterior approach can improve the clinical outcome of the victims of this disease. This uncertainty persists despite the fact that decompression is a logical answer to the stenotic process and that this approach is supported experimentally [16]. Many important variables, however, play a role in a clinical situation that could be different from the experimental conditions in animals. Moreover, the surgery is associated with various risks [14, 35, 52], including the risk of operating on an irrelevant stenotic process (e.g. in patients with ALS, MS, normotensive hydrocephalus) and even a risk of perioperative mortality, with a major morbidity rate of up to 22%, e.g. with corpectomy [29]. Twenty-five percent of patients with the laminoplasty suffer from severe neck and shoulder pain for more than 3 months [18], with significant morbidity from the iliac crest donor site etc.

Excellent outcomes for surgery have been presented in many studies. All of the studies, however, are retrospective, and many a lack clear design, standard criteria, control groups, and sufficient follow-up, so it is difficult to compare [13, 17, 22, 30, 32, 39, 40, 45, 50, 51 ]. Furthermore, several studies and critical reviews are not so optimistic. They claim that surgical treatment of myelopathy, especially of the mild and moderate forms, has not shown better results than conservative treatment in the long-term, and criteria for the indication and the timing of the operation have not been established [4, 10, 24]. Prospective studies showing the advantages of the operative treatment are still lacking [10, 37, 45].

In order to get some more reliable data, a prospective randomised clinical study was started in 1993 to compare the effects of conservative versus surgical treatment in a group of patients with mild and moderate forms of SCM.

 

Materials and methods

Experimental design

A 2-year follow-up prospective randomised clinical study was performed. A group of patients with mild or moderate clinical myelopathy was randomised (using coin toss) into two groups, to be treated surgically or conservatively. Two blinded independent investigators graded video recordings. The local Ethical Committee granted ethical approval, and each patient gave informed consent.

 

Population

The study sample consisted of 48 consecutive subjects, chosen from patients referred to the neurological department between 1993 and 1997 with clinical signs and symptoms of mild to moderate cervical spondylotic myelopathy (37 men and 11 women, mean age 54.2 + 8.5 years). The following inclusion criteria were used:

  • Clinical signs and symptoms of cervical cord dysfunction
  • Magnetic resonance imaging (MRI) criteria for cervical mono- and multisegmental cord compression and/or myelopathy due to spondylosis (including soft disc herniations --see below) with or without developmentally narrow spinal canal
  • Age under 75 years
  • Modified Japanese Orthopaedic Association score ? 12 points.
  • Patient’s consent to surgery

Patients were excluded from the study on the following criteria:

  • Decompensated depression
  • Vascular encephalopathy (dementia, hemiparesis, aphasia)
  • Contraindications to surgery: diabetes mellitus, alcoholism, cardiovascular and lung diseases, blood dyskrasias, significant osteoporosis,
  • Previous surgery on the cervical spine
  • Inability to engage actively in a postoperative rehabilitation
  • Uncertainty about the presence of significant additional diseases (such as MND, MS, progressive polyarthritis);

Subjects who fulfilled the inclusion criteria and in whom other possible causes of clinical signs and symptoms were excluded [9] were enrolled into the 2-year follow-up and randomised into groups that underwent either conservative therapy (group A, 27 patients, mean age 55.6 ± 8.6 years, 22 men and 5 women) or surgical therapy (group B, 21 patients, mean age 52.7 ± 8.1 years, 16 men and 5 women). The mean duration of the symptoms was 6.4 ± 9.9 years (range 0.2--36 years) in group A and 9 ± 8.2 years (range 1--23 years) in group B. There was no significant difference between these two groups in age (p=0.22), sex (p=0.86), duration of illness (p= 0.35), the diameter of the spinal canal (p=0.23), or mJOA score (p= 0.51)- evaluated by t- and c 2 tests.

 

Clinical evaluation

Clinical grading

The clinical grading system proposed by the Japanese Orthopaedic Association and modified by Benzel et al. [1] (mJOA -- maximum 18 points) was utilised to quantify neurological function before enrolment in the study and at 6, 12 and 24 months. The mean mJOA score at enrolment to the study was 14.2 ± 1.3 points, and 13.7 ± 1.8, in groups A and B, respectively. The recovery rate was evaluated at the same time points. Each value was compared to the initial mJOA score (not to the score reached at the previous end point). It was calculated according to the following formula:

Postoperative (or follow-up) score - preoperative (or initial) score

RR= ------------------------------------------------------------------------------------ x 100

18 (normal condition)- preoperative (or initial) score

Evaluation of daily activities by video recording

A video recording was made on enrolment in the study and at 6, 12 and 24 months thereafter. The recordings consisted of patients showing how they buttoned their shirts, brushed their hair and teeth, performed a diadochokinesis, how they put their shoes on, walked and ran, and how they went up and down the stairs. They were evaluated by two physicians, blinded to the type of treatment. The observers assessed the patients´ functional abilities using the following scale: improvement: excellent, +3 points; very good,+2; slightly better, +1; no change, 0, and deterioration: slightly worse, -1; much worse, -2; poor, -3.

Quantified gait (timed 10 m walk)

This was measured as the time (in seconds) spent on 10-m-long track (”walk as fast as possible, but don´t run”) at 0, 6, 12 and 24 months.

Self-evaluation

The same scale as was employed in the video recording evaluation was used for the subjective estimation of the clinical status by the patients themselves at 6, 12 and 24 months.

 

Imaging methods

Plain anteroposterior, oblique and lateral radiographs, and dynamic scans (in flexion and extension), MRI of the cervical cord (sagital and axial planes) in T1, T2 and gradient-echo mode,. and computed tomography (CT) of the cervical region were performed in all patients. The presence of congenital narrowing was identified by measurement of Pavlov’s ratio (the ratio of the anteroposterior diameter of the canal to the vertebral body); it was 0.76 ± 0.13 in group A and 0.8 ± 0.13 in group B. The MRI signs of cervical cord compression at the level of C3- C7 and/or myelopathy were defined as: impingement of the cervical cord (i.e., a concave defect in the spinal cord adjacent to a site of disc bulging, and/or compression of the cervical cord (compression ratio of less than 40%), and/or hyperintensity of the intramedullary T2 signal at the level of cord compression.

Therapy

Significant one-level degenerative stenosis in the surgery group (B) was found in 12 patients, two-level stenosis in 7 patients and three-level in 2 patients. Seventeen patients were operated at the level C5-6, eight at C4-5, six at C3-4, and four at C6-7. Three types of surgical procedures were performed in this series, most of them (n=13) anterior decompression, in nine cases combined with osseous graft and in three without it. Five patients underwent a corpectomy and three a laminoplasty. Internal fixing with a Caspar plate was employed in eight patients.

In group A, one level of degenerative stenosis was found in 8 patients, two levels in 14 and three levels in 5. Conservative treatment consisted of intermittent cervical immobilisation with soft collar, the use of anti-inflammatory medications and intermittent bed rest in patients with pain, and the active discouragement of high-risk activities and avoidance of risky environments (physical overloading, getting too cold, movement on slippery surfaces, manipulation therapies, vigorous or prolonged flexion of the head).

The patients in the surgery group underwent similar conservative treatment to the patients (subjects) in the conservative group.

Statistical data analysis

Pairwise or multiple comparisons of the investigated groups of patients were subjected to robust non-parametric statistical tests, predominantly based on assessment of sample distributional patterns. All the ordinal scales of scores (daily activity score, subjective estimation, and recovery rate) were subsequently re-categorised with respect to the aims of study in order to obtain relatively frequent subgroups of patients. These reasonable combinations of individual score values increased the power of the applied statistical tests (41, 53).

 

The relative frequency profiles of more than two score records and recovery rate nearly covered the whole spectrum of possible values (0 – 100 %) and revealed substantial differences from normal distribution, namely in the range 0 – 25 %. The binomial estimates (P) were then subjected to arcsine and square-root transformation.

(ptr = arcsineodmocnina p)

 

which made the underlying distribution near to normal. After statistical processing, all the binomial data were transformed back by sine function and expressed in original values (%) with correction for possible bias [53].

Pairwise comparisons of percentages were predominantly based on two sample binomial tests using standard normal approximation (53). For limiting percentages (mainly < 20 %), the computations based on the relationship between F distribution and binomial distribution were applied [3,5]. The t-test and c 2 test were used to compare data for evaluation of other parameters.

 

Intention-to-treat analysis

All patients were treated as per protocol, since only those who agreed with both alternatives (conservative and surgical) prior to randomisation were included. It was not necessary to change the type of treatment during the follow-up.

Results

Modified JOA score

The individual mJOA score in all patients in groups A and B in the three follow-ups, i.e. 6, 12 and 24 months after enrolment in the study or after the surgery, were summarised in Table 1 . Three group B patients died during the follow-up period but their deaths were physically unrelated to the surgery. No significant differences were found within and between the groups over the 24 months of follow-up.

Recovery rate

The recovery rate results are summarised in Table 2. No significant difference was found between the mean values for months 6, 12 and 24 within groups A and B. However, significant differences were revealed between groups A and B (binomial tests, P < 0.05) for the category of recovery rate 0 %, which accounted for a significantly higher proportion of group A patients, and in the category of recovery rate < 0 %, which accounted for a significantly higher proportion of group B patients at the 12 and 24 month follow-ups..

Daily activities

The scores of daily activities as recorded by video are summarised in Table 3. There was no significant difference between results at 6, 12 and 24 months within group A, while both observers found significant deterioration over time within group B. Further, there was a significant difference between groups A and B (binomial tests, P < 0.05). In the category ”no change” (daily activities score =0%), which accounted for a higher proportion of group A patients at all follow-ups, and in the category "deterioration" (daily activities score< 0%), which accounted for a higher proportion of group B patients.

 

Quantified gait (Timed 10 m walk)

The mean values for the time taken to walk 10 m, for both groups at 0, 6, 12, and 24 months are summarised in Table 4. The differences within and between the groups at 6, 12 and 24 months were not statistically significant.

Self-evaluation

The subjective evaluation of their clinical status by the patients themselves is summarised in Table 5. No difference, on average, was found within group A over the 24 months. A significant mean subjective deterioration was found in group B between months 6 and 12 (P < 0.05) and months 6 and 24 (P<0.05), and significant differences were revealed between groups A and B (binominal tests, p<0.05), due to a higher proportion of group A patients in the category”no change” and a higher proportion of group B patients in the subjective estimation category score of < 0%. On the other hand, the subjective evaluation category score > 0% accounted for a significantly higher proportion of group B patients month 6, though this was no longer the case by months 12 and 24.

 

 

Discussion

In general, the basic information required for a decision on the treatment the of SCM consists of the natural history of the disease and the effects of conservative and operative treatments. The natural history of SCM has still not been thoroughly documented [23]. There is a tendency for SCM patients to progress to severe disability, but it is not known how much, how fast and how many patients in the population might suffer and what method is suitable for identifying these patients beforehand. Reports of some series refer to a steady progression in all patients [7, 11, 31, 38], while another study reported only 67% patients as having steady, progressive deterioration [42]. On the other hand, yet another retrospective study showed that the disability is mild in the majority of cases, and that the prognosis for these mildly affected cases and even for more severely disabled is good [32], confirming similar findings of a previous study of Lees and Turner in 1963 [26]. The only feature associated with deterioration was the age. Retrospective studies, however, are prone to a significant bias. In summary, we can say that the natural history is not precisely known, and there is a tendency to deteriorate, to remain stable or to improve with approximately the same degree of probability. There is no reliable prognostic factor known that enables the determination of the outcome in an individual patient. Almost all studies are retrospective and lacking in standard and commonly accepted criteria; they merely yield some plausible hypotheses.

Many investigators have employed treatment with a cervical collar or simple observation, and have noted improvement in 29 %--55% of their patients [6, 33, 36, 47]. A conservative approach to the treatment of SCM is supported by a very long history of myelopathy in some patients, which can last 30 and more years without any major deterioration [49]. In the present study, the mean duration of illness was 6.4 years ± 9,9 year. It reached more than 10 years in five of the patients, 4 years for more than 16, and for one patient it has lasted 36 years. Our results in conservatively treated group (A) showed, on average, no significant change over the 2 years of follow-up regarding the evaluation of daily activities, the mJOA scale and recovery rate, the speed of gait and the subjective assessment. This does not mean that there were no changes in individual patients. Five patients improved on the mJOA scale by 2 points, one by 3 points and one by 5 points, one patient deteriorated by 5 points, one by 2 and one by 3 points. In no case in group A was an operation carried out in the course of the 2 years, not even on the patient with the 5-point decline, because he was reluctant to have surgery (despite his initial consent) and his gait was quite good. Our results showed a relatively benign history for these conservatively treated mild and moderate forms of SCM as a group. We could speculate over whether this is due to a benign natural course and whether, and to what extent, it is influenced by the conservative treatment, especially the exclusion of patients from the physical overloading (stopping the hard physical work), intermittent use of soft collar, etc. We suggest that the pain, which usually brings the patients to a physician, could be a very potent preventive factor, as it is in many other diseases. The lack of pain and killing the pain without limiting potentially harmful activities and stress, on the other hand, could accelerate the ”insidious and silent” progress of the disease.

Operative treatment for SCM has been a popular form of therapy for nearly 40 years. Present surgical methods include anterior (Cloward or Smith-Robinson technique [40]) or posterior (laminectomy, hemilaminectomy) approach, both with good and probably equal results; and recently open-door laminoplasty and vertebral corpectomy have been added [21]. The indication for surgery is mostly a severe and progressive course of the disease. To the best of our knowledge, no comparison of the effects of conservative and operative treatments has been made in a randomised controlled trial. Almost all published reports come from surgical departments and are retrospective. In many surgical and orthopaedic departments, however, almost all cases of SCM referred by neurologists are operated without considering the grade of functional deficit [20]. Very little is known about the operation in patients with a the definite but mild or moderate form without progression, who represent the large majority of patients with SCM and in whom the surgery is more logical (to prevent unpredictable and severe deterioration). Because irreversible changes may occur in the spinal cord, the best results are obtained in patients who have decompression within six months to one year after the onset of symptoms and in those who have early, mild myelopathic findings [12, 15, 27].

In this study, the mean changes within the surgery group were not significant. This held true for the mJOA score, the recovery rate, the video records, and the gait. The only significant difference was in the subjective assessment, which deteriorated slightly over the two years. There were, of course, changes in individual patients: one patient improved by 4 points on the mJOA scale, two patients by 3 points, and two by 2 points. Two patients deteriorated by 2 points, two by 3 points, and one by 4 points. Three patients expired during the follow-up in group B. All of them committed suicide in a state of depression that was not a consequence of decline in clinical status after surgery. The significant difference between groups A and B were registered in the score of daily activities recorded by video, RR, and subjective estimation (month 12 and 24) in favour of group A, but only in subjective assessment was the month 6 in favour of group B.

The most favourable papers on SCM suggest that fewer than 70 per cent of patients with SCM subjectively improve after surgery by either an anterior or posterior approach, with and without fusion [2, 8, 45], exceptionally 87.5% [44]. But these favourable short-term results may be balanced out by the unexpectedly high incidence of late deterioration [10, 13]. Some studies report lower percentage of success [19, 28].

The results of our study are hardly comparable to other studies, because we were unable to find any controlled studies, and retrospective series suffer with all the usual drawbacks. Only minor neurological changes were documented in our study in both the groups compared over the two years. We expected improvements in the surgery group and decline among the patients treated conservatively. This did not prove to be the case. The group of conservatively treated patients did not differ in this study from those treated operatively in many parameters over the 2 years of follow-up. The only significant difference between the two groups was in score of daily activities recorded by video at 12 and 24 months, in RR and in subjective assessment and was in favour of non-operative treatment. In both groups some individual patients improved and some deteriorated.

In conclusion, this study did not show any substantial difference in the average outcome, over a period of 2 years, of patients suffering from mild and moderate forms of SCM according to whether they were treated conservatively or surgically. Improvement and deterioration in the condition of individual patients occurred in both groups. Who is suitable for which type of therapy may hopefully answered by an analysis within the subgroups of the patients who improved and those who deteriorated in a larger study with a longer follow-up. The 2 years of follow-up could be too short to disclose the benefit of the surgery in this group of patients.

 

Conclusions

  1. The current study comprising the patients with no or very slow, insidious progression only showed, on average, no significant deterioration in mJOA score, recovery rate, and quantified gait time within the two groups during the 2 years of follow-up. The subjective evaluation and the score of daily activities in surgical group declined slightly at month 24 (and to a lesser extent 12) in comparison with month 6.
  2. Comparison of the two groups showed significant difference in the score of daily activities recorded by video, in recovery rate, and in subjective evaluation by patients at 12 and 24 months, all of which were worse in the in surgical group.
  3. The surgical treatment of mild and moderate forms of SCM in present study design showed no better results than conservative treatment over 2 years of follow up.

 

 

References

 

  1. Benzel EC, Lancon J, Kesterson L, Haden, T (1991) Cervical laminectomy and dentate ligament section for cervical spondylotic myelopathy. J Spin Disord 4:286-295.
  2. Bertalanffy H, Eggert HR (1988) Clinical long-term results of anterior cervical discectomy without fusion for treatment of cervical radiculopathy and myelopathy. Acta Neurochir (Wien) 90:127-135.
  3. Bliss, CI (1967) Statistics in Biology, Vol.1, McGraw-Hill, New York, 558pp.
  4. Braakman R (1994) Management of cervical spondylotic myelopathy and radiculopathy. J Neurol Neurosurg Psychiat 57:257-263.
  5. Brownlee, KA (1965) Statistical theory and methodology in science and Engineering, 2nd Ed, John Wiley, New York , 590 pp.
  6. Brain WR, Northfield D, Wilkinson M (1952) Neurological manifestations of cervical spondylosis. Brain 75:187-225.
  7. Clarke E, Robinson PK (1956) Cervical myelopathy: A complication of cervical spondylosis Brain 79:483-510.
  8. Cusick JF (1991) Pathophysiology and treatment of cervical spondylotic myelopathy. Clin Neurosurg 37:661-681.
  9. Dvořák J, Janssen B, Grob D (1990) The Neurologic Workup in Patients with Cervical Spine Disorders. Spine 15:1017-1022.
  10. Ebersold MJ, Pare MC, Quast CM (1995) Surgical treatment for cervical spondylitic myelopathy. J Neurosurg 82:745-751.
  11. Epstein JA, Janin Y, Carras R, Lavine I.S (1982) A comparative study of the treatment of the cervical spondylotic myelopathy. Experience with 50 cases treated by means of extensive laminectomy, foraminotomy, and excision of osteophytes during the past 10 years. Acta Neurochir 61:89-104.
  12. Epstein JA, Epstein NE (1989) The surgical management of cervical spinal stenosis, spondylosis, and myeloradiculopathy by means of the posterior approach. In: Cervical Spine Research Society Editorial Committee (eds) The cervical Spine. J.B. Lippincott, Philadelphia, pp 625-643.
  13. Goto S, Mochizuki M, Watanabe T, Hiramatu K, Tanno T, Kitahara H, Moriya H (1993) Long-term follow-up study of anterior surgery for cervical spondylotic myelopathy with special reference to the magnetic resonance imaging findings in 52 cases. Clin Orthop Rel Res 291:142-153.
  14. Guigui P, Benoist M, Deburge A (1998) Spinal deformity and instability after multilevel cervical laminectomy for spondylotic myelopathy. Spine 23:440-447.
  15. Hamburger C, Buttner A, Uhl E (1997) The cross-sectional area of the cervical spinal canal in patients with cervical spondylotic myelopathy. Correlation of preoperative and postoperative area with clinical symptoms. Spine 22:1990-1994.
  16. Harkey HL, Al-Mefty O, Marawi I, Peeler DF, Haines DE, Alexander LF (1995) Experimental chronic compressive cervical myelopathy: effects of decompression. J Neurosurg 83:336-341.
  17. Hirai O, Kondo A, Aoyama I., Nin, K (1991) Anterior decompression surgery of aged patients with cervical myelopathy. No Shinkei geka 19:1017-1023.
  18. Hosono N, Yonenobu K, Ono K (1996) Neck and shoulder pain after laminoplasty. A noticeable complication. Spine 21:1969-1973.
  19. Jeffreys RV (1986) Surgical treatment of cervical myelopathy due to spondylosis and disc degeneration. J Neurol Neurosurg Psychiat 49:353-361.
  20. Kadaňka Z, Bednařík J, Voháňka S, Vlach O (1996) Operative management of spondylotic cervical myelopathy in Czech and Slovak Republic. Rozh Chir 75:535-540.
  21. Kohno K, Kumon Y, Oka Y, Matsui S, Ohue S, Sakaki S (1997) Evaluation of prognostic factors following expansive laminoplasty for cervical spinal stenotic myelopathy. Surg Neurol 48:237- 245.
  22. Koyanagi T, Hirabayashi K, Satomi K, Toyama Y, Fujimura Y (1993) Predictability of operative results of cervical compression myelopathy based on preoperative computed tomographic myelography. Spine 1993:1958-1963.
  23. LaRocca H (1988) Cervical spondylotic myelopathy: natural history. Spine 13:854-855.
  24. Law MD, Bernhardt M, White AA (1994) Cervical spondylotic myelopathy: A review of surgical indications and decisions making. Yale J Biol Med 66:165-177.
  25. Law MD, Bernhardt M, White AA (1994) Evaluation and management of cervical spondylotic myelopathy. J Bone Joint Surg (Am.) 76:1420-1433.
  26. Lees F, Turner JWA (1963) Natural history and prognosis of cervical spondylosis in a general practice. Br Med J 2:1607-1610.
  27. Lesoin F, Bouasakao N, Clarisse J, Rouseaux M, Jomin M (1985) Results of surgical treatment of radiculomyelopathy caused by cervical arthrosis based on 1000 operations. Surg Neurol 23:350-355.
  28. Lundsford LD, Bissonette DJ, Zorub DS (1980) Anterior surgery for cervical disc disease. Part 2. Treatment of cervical spondylotic myelopathy in 32 cases. J Neurosurg 53:12-19.
  29. MacDonald RL, Fehlings MG, Tator CH, Lozano A, Fleming JR, Gentili F, Bernstein M, Wallace MC, Tasker RR (1997) Multilevel anterior cervical corpectomy and fibular allograft fusion for cervical myelopathy. J Neurosurg 86:990-997.
  30. Magnaes B, Hauge T (1980) Surgery for myelopathy in cervical spondylosis: safety measures and preoperative factors related to outcome. Spine 5:211-213.
  31. Montgomery DM, Brower RS (1992) Cervical spondylotic myelopathy. Clinical syndrome and natural history. Orthop Clin North America 23:487-493.
  32. Nurick S (1972) The pathogenesis of the spinal ford disorder associated with cervical spondylosis. Brain 95:87-100.
  33. Phillips DG (1973) Surgical treatment of myelopathy with cervical spondylosis. J Neurol Neurosurg Psychiat 36:879-884.
  34. Quenouille MH (1950) Introductory statistics. Butterworth-Springer.London.
  35. Rao S, Badani KM, Jamieson K, Schildhauer T (1996) Pitfalls in the surgical management of the cervical spine surgery. Eur Spin J 5:153-160.
  36. Roberts AH (1966) Myelopathy due to cervical spondylosis treated by collar immobilization. Neurology 16:951-954.
  37. Rowland LP (1992) Surgical treatment of cervical spondylotic myelopathy. Time for a controlled trial. Neurology 42:5-13.
  38. Sadasivan KK, Reddy RP, Albright JA (1993) The natural history of cervical spondylotic myelopathy. Yale J Biol Med 66: 235-242.
  39. Seifert V, Stolke D (1991) Multisegmental cervical spondylosis: treatment by spondylectomy, microsurgical decompression, and osteosynthesis. Neurosurgery 29:498- 503.
  40. Smith GW, Robinson RA (1958) The treatment of certain cervical-spine disorders by anterior removal of the intervertebral disc and interbody fusion. J Bone Joint Surg 40:607-624.
  41. Snedecor GW, Cochran, WG (1980) Statistical methods. 7thed. Iowa State University Press. Iowa. USA. 711 pp.
  42. Symon L, Lavender P (1967) The surgical treatment of cervical spondylotic myelopathy. Neurosurg 17:117-127.
  43. Tegos S, Rizos K, Papathanasiu A, Kyriakopulos, K (1994) Results of anterior discectomy without fusion for treatment of cervical radiculopathy and myelopathy. Eur Spine J 3:62-65.
  44. Teramoto T, Ohmori K, Takatsu T, Inoue H, Ishida Y, Suzuki K (1994) Long-term results of the anterior cervical spondylodesis. Neurosurg 35:64-68.
  45. Utley D, Monro P (1989) Neurosurgery for cervical spondylosis. Br J Hosp Med 42:62-70.
  46. Vadeboncoeur R, Milette PC, Perreault N (1994) Cervical myelopathy and disc herniations: A study of 58 cases with magnetic resonance imaging. Discussion on complications of cervical manipulation. Man Med 32:91-94.
  47. Whiteson JH, Panaro N, Ahn JH, Firooznia H (1997) Tetraparesis following dental extraction: case report and discussion of preventive measures for cervical spinal hyperextension injury. J Spinal Cord Med 20:422-425.
  48. Wilkinson M (1960) The morbid anatomy of cervical spondylosis and myelopathy. Brain 83: 589-616.
  49. Yamashita M, Yamamoto T (1955) A case of very slowly progressive, high-cervical spondylotic myelopathy presenting with symmetric deep sensory deficits in the palms. No To Shinkei 47:893-897.
  50. Yangia OU, Jike L, Jite M, Cheng-li, Jianghui Z, Yujun L, Ning Jiang S (1994) Extensive anterior decompression for mixed cervical spondylosis. Resection of uncovertebral joints, neural and transverse foraminotomy, subtotal corpectomy, and fusion with strut graft. Spine 23:2651- 2657.
  51. Yonenobu K, Okada K, Fuji T, Fujiwara K (1985) Causes of neurologic deterioration following surgical treatment of cervical myelopathy. Spine 11:818-823.
  52. Yonebobu K, Hosono N, Iwasaki M, Asano M, Ono K (1991) Neurologic complications of surgery for cervical spondylotic myelopathy. Spine 16:1277- 1282.
  53. Zar JH (1984) Biostatistical analysis. 2nd ed. Prentice Hall. London, 686 pp.

 

Table 1. Average values with standard deviations of the modified JOA score in groups A (conservative treatment) and B (surgical treatment) at months 0, 6, 12, and 24.

mJOA score
  Group A Group B

Month

Mean SD Mean SD
0 14.3 1.3 13.7 1.7
6 14.5 2.0 13.4 1.7
12 15.1 1.9 13.3 1.7
24 14.5 1.8 13.7 2.0

 

 

Table 2. Recovery rate (RR) within groups A (conservative treatment) and B (surgical treatment) at months 6, 12 and 24 of follow-up: the values presented represent the proportion of patients from each group who reached the given values of RR at the given time points

Categorised

RR

values

Group A

Group B

6 months

12 months

24 months

Binomial

tests a

6 months

12 months

24 months

Binomial tests 2

RR< - 40 %

14.8

14.8

18.5

P = 0.158

28.6

33.3

33.3

P = 0.215

-40 %

11.1

3.7

3.7

14.3

19.0

14.3

RR=0%

44.4

48.2

37.0

P = 0.475

23.8

14.3

28.6

P = 0.275

0 % < RR < 40 %

18.6

22.2

14.8

P = 0.698

19.0

19.0

9.5

P = 0.363

RR > 40 %

11.1

11.1

26.0

14.3

14.4

14.3

 

a Significance level of multiple binomial tests, comparing monitored time periods within groups A and B. Statistical comparisons were performed separately for score 0 and for summarised positive and negative recovery rate values. There were no significant differences within either group during the follow-up.

 

 

Table 3. Summarised assessment of daily activities recorded by video in conservatively (group A) and surgically (group B) treated patients, as evaluated by two independent and blinded observers a, presented as detailed distribution (%) of cases reaching the category of given score (I) and summarised positive and negative scores (%) supplied with standard error of estimates (II)

Daily activities

score

Group A 1

Group B 1

6 months 2

12 months 2

24 months 2

Binomial

tests 3

6 months 2

12 months 2

24 months 2

Binomial tests 3

I

II

I

II

I

II

I

II

I

II

I

II

-3

0

7.4

(1.8)

0

7.4

(1.8)

0

18.5

(7.2)

 

p = 0.796

2.4

23.9

(9.5)

0

21.4

(9.1)

0

42.8

(11.1)

p = 0.038

-2

3.7

0

0

4.8

7.1

19.0

-1

3.7

7.4

18.5

16.7

14.3

23.8

0

85.2 (7.9)

79.6 (9.0)

70.4 (10.2)

p = 0.256

57.1 (11.1)

71.5 (10.1)

52.4 (11.2)

p = 0.157

1

7.4

7.4

(1.8)

12.9

12.9

(4.4)

11.1

11.1

(3.9)

 

p = 0.883

14.3

19.1

(8.7)

7.1

7.1

(1.6)

4.8

4.8

(1.1)

p = 0.021

2

0

0

0

2.4

0

0

3

0

0

0

2.4

0

0

 

a Because no significant difference was detected between the observers (test of homogeneity of binomial distributions), the registered values were combined prior to setting up the table. Where possible, estimates of percentage was supplied by standard errors (in parentheses)

 

bSignificance level of multiple binomial tests, comparing the score at the different follow-up points within groups A and B. Statistical comparisons were performed separately for score 0 and for summarised positive and negative records

 

 

Table 4. The quantified gait (mean and SD) on a 10-m long track in groups A and B at months 0, 6, 12 and 24.

Gait
  Group A Group B
Month Mean time (s) SD (s) Mean time (s) SD (s)
0 8.3 s 4.3 10.7 s 7.0
6 7.7 s 2.6 12.0 s 10.8
12 8.0 s 2.9 12.0 s 11.0
24 8.0 s 2.9 12.9 s 10.6

 

 

Table 5. Subjective evaluation of the disease course by the patients within groups A (conservative treatment) and B (surgical treatment) at the 6-, 12- and 24-months follow-ups, presented as distribution (%) of cases in each category of the scale (I), and summary of positive, non-changed and negative values supplied with standard errors of estimates (II)

 

Score of subjective estimation

Group A 1

Group B 1

6 months 2

12 months 2

24 months 2

Binomial

tests 3

6 months 2

12 months 2

24 months 2

Binomial tests 3

I

II

I

II

I

II

I

II

I

II

I

II

-3

0

33.3

(10.5)

0

44.5

(11.1)

0

33.3

(10.5)

 

p = 0.303

0

23.8

(9.5)

9.5

52.1

(11.2)

14.3

57.2

(11.1)

p = 0.002

-2

7.4

11.1

7.4

9.5

4.8

4.8

-1

25.9

33.3

25.9

14.3

38.1

38.1

0

40.7 (10.9)

40.7 (10.9)

55.6 (10.2)

p = 0.175

19.0 (11.1)

33.3 (10.1)

28.6 (11.2)

p = 0.653

1

18.5

26.0

(9.8)

14.8

14.8

(4.4)

11.1

11.1

(4.1)

 

p = 0.315

38.1

57.2

(11.1)

14.3

14.3

(5.8)

9.5

14.3

(5.8)

p < 0.001

2

3.7

0

0

14.3

0

4.8

3

3.7

0

0

4.8

0

0

Significance level of multiple binomial tests comparing 6-,12-, and 24- month- follow-up scores within groups A and B. Statistical comparisons were performed separately for score 0 and for summarised positive and negative scores

Informace o pohotovosti v Brně a Jihomoravském kraji